NCBI PubMed Central
open access
Who receives psychiatry-focused pharmacogenomic testing, and is it associated with prescribing patterns and acute care utilisation in depression? Real-world evidence from a large health system.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Psychiatric pharmacogenomics: from genetic evidence to clinical integration – structural, educational, and ethical challenges.#122838
- Systematic Genetic Analysis of Phenomenology and Treatment Response in Mood Disorders#829664
- Pharmacogenomics of antiepileptic drug mood stabilizer treatment response in bipolar disorder: A MoStGen Consortium study#224186
- Assessment of the Impact of Clinical Pharmacogenomics on Real and Potential Medication Use in Veterans#902857
- Implementation of preemptive pharmacogenetic testing: progress, puzzles and priorities from an implementation science perspective.#1097917
Record · ID 170657
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive